Drug facts
Oral semaglutide: the Wegovy pill vs the injection
Quick answer
Yes. An approved semaglutide tablet exists, with its own escalation schedule ending at 25 mg once daily and strict instructions about how it is swallowed. That is the sharpest contrast with tirzepatide, where no approved product is a tablet at all. A compounded “oral semaglutide” is still not that product.
Yes — and that is the difference1
Anyone arriving from a page about oral tirzepatide should notice the answer flip. There, the honest answer is that no approved tirzepatide product is taken by mouth. Here, one is: the same brand ships both an injection and a tablet, under one label, with separate sections for each.
The tablet schedule1
It is daily rather than weekly, and it climbs by days rather than weeks:
- Days 1–30
- 1.5 mg once daily
- Days 31–60
- 4 mg once daily
- Days 61–90
- 9 mg once daily
- Day 91 onward
- 25 mg once daily
The milligram numbers are much larger than the injection’s, and that is not a stronger dose — it is the same molecule taken by a route that absorbs far less of it. Comparing 25 mg daily against 2.4 mg weekly as if they were the same scale is the most common mistake made with this page’s subject.
If the 25 mg maintenance dose is not tolerated, the label says to consider switching to the injection at 1.7 mg once weekly.
How it has to be taken2
The instructions are unusually strict, and they are the reason the tablet works at all: once daily on an empty stomach in the morning, with no more than four ounces of plain water — no other liquid — swallowed whole, never split, crushed, chewed or dissolved, and then at least 30 minutes before any food, any other drink, or any other oral medicine.
Nothing about that is optional packaging advice. An oral peptide has to survive the stomach, and the timing is what gives it the chance.
Switching between the two3
The label gives a rule in each direction, and they are not symmetrical. From the 2.4 mg injection to 25 mg tablets: start the tablets one week after the last injection. From 25 mg tablets to the injection: start the day after the last tablet.
What is sold as “oral semaglutide”1
On the label — Wegovy / Ozempic
A tablet with an approved formulation, an absorption enhancer that was reviewed, a fixed strength and a tested schedule.
In a compounded vial
Usually a liquid or a troche, not the approved tablet. It has no label, no established bioavailability, and the escalation above does not describe it. Whatever the milligram figure on it says, it is not comparable to 25 mg of the approved tablet.
The practical consequence is that a price per milligram means very little across routes. What each seller charges per calendar month is on the index, and the dose it is charging for is worth reading carefully.
Sources
- FDA prescribing information for WEGOVY (semaglutide), section 2.3 Recommended Dosage for WEGOVY Tablets, revision 6/2026 DailyMed
- FDA prescribing information for WEGOVY (semaglutide), section 2.1 Important Monitoring and Administration Instructions, revision 6/2026 DailyMed
- FDA prescribing information for WEGOVY (semaglutide), section 2.5 Switching Between WEGOVY Injection and WEGOVY Tablets, revision 6/2026 DailyMed